BioAdge Labs Shares Are Trading Lower After Jefferies Downgraded the Stock From Buy to Hold and Citigroup Downgraded the Stock From Buy to Neutral. Additionally, Both Firms Cut Their Price Target on the Stock to $7.
BioAdge Labs Shares Are Trading Lower After Jefferies Downgraded the Stock From Buy to Hold and Citigroup Downgraded the Stock From Buy to Neutral. Additionally, Both Firms Cut Their Price Target on the Stock to $7.
在傑富瑞將股票評級從買入下調至持有，花旗集團將股票評級從買入下調至中立後，BioAdge Labs的股價下跌。此外，兩家公司均將該股的目標價下調至7美元。
BioAdge Labs Shares Are Trading Lower After Jefferies Downgraded the Stock From Buy to Hold and Citigroup Downgraded the Stock From Buy to Neutral. Additionally, Both Firms Cut Their Price Target on the Stock to $7.
在傑富瑞將股票評級從買入下調至持有，花旗集團將股票評級從買入下調至中立後，BioAdge Labs的股價下跌。此外，兩家公司均將該股的目標價下調至7美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間